X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4737) 4737
Book Review (557) 557
Publication (377) 377
Book Chapter (12) 12
Dissertation (12) 12
Book / eBook (10) 10
Conference Proceeding (5) 5
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4448) 4448
humans (4371) 4371
female (4001) 4001
oncology (2156) 2156
middle aged (2088) 2088
cancer (2049) 2049
carcinoma (1700) 1700
aged (1673) 1673
immunohistochemistry (1606) 1606
adult (1556) 1556
ovarian cancer (1369) 1369
prognosis (1268) 1268
ovarian neoplasms - pathology (1202) 1202
ovarian neoplasms - metabolism (1182) 1182
pathology (1182) 1182
expression (1174) 1174
endometrial neoplasms - metabolism (1050) 1050
endometrial neoplasms - pathology (1040) 1040
tumors (1021) 1021
endometrial cancer (887) 887
aged, 80 and over (845) 845
biomarkers, tumor - metabolism (835) 835
obstetrics & gynecology (802) 802
cell line, tumor (784) 784
neoplasm staging (746) 746
carcinoma, endometrioid - metabolism (734) 734
gene expression (721) 721
ovarian neoplasms - genetics (712) 712
gene expression regulation, neoplastic (701) 701
breast-cancer (684) 684
analysis (680) 680
carcinoma, endometrioid - pathology (680) 680
research (655) 655
metastasis (626) 626
animals (621) 621
cell biology (574) 574
proteins (573) 573
endometrial neoplasms - genetics (557) 557
genetic aspects (530) 530
adenocarcinoma (514) 514
mutation (508) 508
survival (488) 488
development and progression (484) 484
endometrial carcinoma (464) 464
chemotherapy (451) 451
male (440) 440
apoptosis (438) 438
ovarian carcinoma (413) 413
research article (394) 394
cells (390) 390
mice (378) 378
carcinoma, ovarian epithelial (369) 369
cell proliferation (360) 360
diagnosis (346) 346
health aspects (343) 343
care and treatment (342) 342
signal transduction (340) 340
medical prognosis (331) 331
carcinoma, endometrioid - genetics (326) 326
genes (326) 326
medicine (325) 325
adenocarcinoma - metabolism (324) 324
p53 (318) 318
mutations (311) 311
article (309) 309
cystadenocarcinoma, serous - metabolism (309) 309
biochemistry & molecular biology (307) 307
endometrium (302) 302
disease progression (299) 299
obstetrics and gynecology (299) 299
ovarian neoplasms - drug therapy (298) 298
retrospective studies (298) 298
gene (293) 293
biomarkers (290) 290
neoplasms, glandular and epithelial - pathology (287) 287
cancer research (283) 283
neoplasm invasiveness (282) 282
hematology, oncology and palliative medicine (281) 281
medicine & public health (281) 281
adenocarcinoma - pathology (279) 279
biomarkers, tumor - analysis (276) 276
breast cancer (276) 276
gene-expression (275) 275
survival analysis (275) 275
cystadenocarcinoma, serous - pathology (273) 273
multidisciplinary sciences (273) 273
overexpression (273) 273
biomarkers, tumor - genetics (270) 270
risk factors (265) 265
ovarian neoplasms - mortality (263) 263
reverse transcriptase polymerase chain reaction (262) 262
ovarian neoplasms - diagnosis (260) 260
growth (258) 258
kaplan-meier estimate (258) 258
tumor suppressor protein p53 - metabolism (255) 255
disease-free survival (254) 254
protein (252) 252
case-control studies (251) 251
studies (251) 251
kinases (250) 250
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4664) 4664
Chinese (64) 64
Polish (10) 10
Japanese (4) 4
Spanish (4) 4
Russian (3) 3
Czech (2) 2
German (2) 2
Romanian (2) 2
French (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Cell, ISSN 1535-6108, 04/2007, Volume 11, Issue 4, pp. 321 - 333
One histologic subtype of ovarian carcinoma, ovarian endometrioid adenocarcinoma (OEA), frequently harbors mutations that constitutively activate... 
CELLCYCLE | EPITHELIAL-MESENCHYMAL TRANSITION | GENE-MUTATIONS | K-RAS | ONCOLOGY | MICROSATELLITE INSTABILITY | FUNCTIONAL-EVALUATION | PROSTATE-CANCER | HIGH-FREQUENCY | EXPRESSION PATTERN | BETA-CATENIN | CLINICOPATHOLOGICAL FEATURES | Adenomatous Polyposis Coli Protein - physiology | Wnt1 Protein - genetics | Oligonucleotide Array Sequence Analysis | Adenocarcinoma, Mucinous - pathology | Humans | PTEN Phosphohydrolase - physiology | Cystadenocarcinoma, Serous - metabolism | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Gene Expression Profiling | Phosphatidylinositol 3-Kinases - metabolism | Wnt1 Protein - metabolism | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | Tumor Suppressor Protein p53 - genetics | Carcinoma, Endometrioid - metabolism | Ovarian Neoplasms - genetics | Female | Ovarian Neoplasms - metabolism | Disease Models, Animal | Ovary - metabolism | Adenomatous Polyposis Coli Protein - genetics | PTEN Phosphohydrolase - genetics | Carcinoma, Endometrioid - genetics | Epithelium - pathology | Ovary - pathology | Epithelium - metabolism | Signal Transduction | Adenocarcinoma, Clear Cell - metabolism | Tumor Suppressor Protein p53 - metabolism | Survival Rate | beta Catenin - metabolism | beta Catenin - genetics | Phosphatidylinositol 3-Kinases - genetics | Animals | Adenocarcinoma, Mucinous - metabolism | Adenocarcinoma, Clear Cell - pathology | Mice | Adenocarcinoma, Mucinous - genetics | Mutation | Neoplasm Staging | Adenocarcinoma, Clear Cell - genetics | Carcinoma, Endometrioid - pathology | Index Medicus
Journal Article
Journal Article
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 10/2009, Volume 33, Issue 10, pp. 1504 - 1514
Uterine serous carcinomas typically have a characteristic morphology (papillary architecture, high-grade nuclei) and immunoprofile (diffuse/strong p53... 
Adenocarcinoma | Immunohistochemistry | P16 | Uterus | Endometrioid carcinoma | Serous carcinoma | Endocervical adenocarcinoma | SURGERY | DIFFERENTIAL-DIAGNOSIS | CERVICAL ADENOCARCINOMAS | FEMALE GENITAL-TRACT | MICROSATELLITE INSTABILITY | adenocarcinoma | DRUG-RESISTANCE | PATHOLOGY | HUMAN-PAPILLOMAVIRUS DNA | OVARIAN-CARCINOMA | uterus | p16 | P53 GENE-MUTATIONS | endocervical adenocarcinoma | immunohistochemistry | PROGNOSTIC-SIGNIFICANCE | serous carcinoma | endometrioid carcinoma | CLEAR-CELL CARCINOMA | Humans | Cystadenocarcinoma, Serous - metabolism | Endometrial Neoplasms - metabolism | Cystadenocarcinoma, Serous - genetics | Carcinoma, Endometrioid - diagnosis | Papillomavirus Infections - diagnosis | Tumor Suppressor Protein p53 - genetics | Carcinoma, Endometrioid - metabolism | Endometrial Neoplasms - genetics | Uterine Cervical Neoplasms - metabolism | DNA Mutational Analysis | Polymerase Chain Reaction | Cyclin-Dependent Kinase Inhibitor p16 - biosynthesis | Female | Uterine Neoplasms - diagnosis | Uterine Neoplasms - genetics | Carcinoma, Endometrioid - genetics | Diagnosis, Differential | Papillomavirus Infections - complications | Uterine Neoplasms - metabolism | Uterine Cervical Neoplasms - diagnosis | Biomarkers, Tumor - analysis | In Situ Hybridization, Fluorescence | Endometrial Neoplasms - diagnosis | Papillomavirus Infections - metabolism | Uterine Cervical Neoplasms - virology | Cystadenocarcinoma, Serous - diagnosis | Index Medicus
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 383, Issue 1, pp. 28 - 40
Abstract Endometrioid endometrial carcinoma (EEC) is the most common gynecologic malignancy around the world. Epithelial-to-mesenchymal transition (EMT) is a... 
Hematology, Oncology and Palliative Medicine | MALAT1 | Endometrioid endometrial carcinoma | miR-200c | Invasion | MALATI | MICRORNAS | MIR-200 FAMILY | COMPETING ENDOGENOUS RNA | EPITHELIAL-MESENCHYMAL TRANSITION | LUNG-CANCER | LONG NONCODING RNA | ONCOLOGY | CANCER METASTASIS | SQUAMOUS-CELL CARCINOMA | PROMOTES | Humans | Endometrial Neoplasms - metabolism | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Carcinoma, Endometrioid - metabolism | Transfection | Endometrial Neoplasms - genetics | RNA Interference | Time Factors | Epithelial-Mesenchymal Transition | Biomarkers, Tumor - metabolism | Female | 3' Untranslated Regions | Binding Sites | Carcinoma, Endometrioid - genetics | Signal Transduction | Neoplasm Invasiveness | RNA, Long Noncoding - genetics | Tumor Burden | Cell Movement - drug effects | Transforming Growth Factor beta - pharmacology | Animals | Mice, Nude | Cell Line, Tumor | Endometrial Neoplasms - pathology | Biomarkers, Tumor - genetics | Mice, Inbred BALB C | MicroRNAs - genetics | RNA, Long Noncoding - metabolism | Carcinoma, Endometrioid - pathology | Medical colleges | Carcinoma | Melanoma | Antisense RNA | Metastasis | Transforming growth factors | Ovarian cancer | Prevention | Analysis | Stem cells | Bone morphogenetic proteins | Health aspects | Cancer | Studies | Medical research | Hospitals | Endometrial cancer | Genes | Chromosomes | Tumors | Index Medicus
Journal Article
FEBS Journal, ISSN 1742-464X, 08/2013, Volume 280, Issue 16, pp. 3768 - 3779
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2010, Volume 363, Issue 16, pp. 1532 - 1543
Journal Article
Journal Article
The Journal of Pathology, ISSN 0022-3417, 09/2017, Volume 243, Issue 1, pp. 26 - 36
Journal Article
14.